Paolo Bruzzi Selected Research

Paolo Bruzzi Research Topics

Disease

46	Breast Neoplasms (Breast Cancer) 09/2022 - 06/2002
37	Neoplasms (Cancer) 01/2022 - 06/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 10/2009
4	COVID-19 10/2022 - 01/2021
4	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2003
4	Fever (Fevers) 01/2021 - 04/2003
4	Infections 01/2018 - 04/2003
3	Disease Progression 12/2021 - 02/2018
3	Neutropenia 01/2018 - 05/2015
3	Cardiotoxicity 10/2017 - 05/2009
3	Multiple Sclerosis 07/2013 - 03/2005
3	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 06/2002
2	Pneumonia (Pneumonitis) 10/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 07/2020 - 01/2015
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 10/2019 - 02/2018
2	Lung Neoplasms (Lung Cancer) 12/2018 - 03/2007
2	Leukemia 01/2018 - 04/2003
2	Hodgkin Disease (Hodgkin's Disease) 10/2017 - 10/2017
2	Thrombocytopenia (Thrombopenia) 01/2017 - 12/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 04/2015
2	Sepsis (Septicemia) 05/2016 - 04/2007
2	Myocardial Infarction 04/2015 - 01/2006
2	Insulin Resistance 10/2013 - 07/2012
2	Chills 05/2010 - 01/2010
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2007 - 01/2002
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022

Drug/Important Bio-Agent (IBA)

13	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 07/2002
10	AnthracyclinesIBA 01/2020 - 07/2002
9	Biomarkers (Surrogate Marker)IBA 02/2019 - 06/2002
7	Estrogen ReceptorsIBA 05/2016 - 12/2005
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 07/2002
6	Pharmaceutical PreparationsIBA 10/2019 - 01/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 08/2004
6	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 07/2002
5	Docetaxel (Taxotere)FDA Link 01/2020 - 10/2008
4	Hormones (Hormone)IBA 10/2021 - 10/2011
4	NivolumabIBA 01/2020 - 01/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 08/2006
3	Tamoxifen FDA LinkGeneric 10/2021 - 09/2006
3	Insulin (Novolin)FDA Link 06/2021 - 07/2012
3	Metformin (Glucophage)FDA LinkGeneric 05/2020 - 07/2012
3	Ifosfamide FDA LinkGeneric 01/2020 - 03/2014
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 02/2014
3	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 01/2017
3	Gemcitabine FDA Link 01/2020 - 03/2013
2	Monoclonal AntibodiesIBA 12/2021 - 10/2008
2	Letrozole (Femara)FDA LinkGeneric 10/2021 - 08/2006
2	C-Reactive ProteinIBA 01/2021 - 11/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2011
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2017
2	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2019
2	TrabectedinIBA 01/2020 - 01/2017
2	LigandsIBA 10/2019 - 01/2010
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 07/2002
2	SmokeIBA 01/2018 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 07/2012
2	ParaffinIBA 05/2013 - 01/2009
2	Filgrastim (Neupogen)FDA Link 01/2013 - 12/2005
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2013 - 12/2005
2	human CNGRC fusion protein tumor necrosis factor-alphaIBA 05/2010 - 01/2010
2	Peptides (Polypeptides)IBA 05/2010 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 10/2003
2	CD13 Antigens (Alanine Aminopeptidase)IBA 05/2010 - 01/2010
2	Protein Isoforms (Isoforms)IBA 05/2010 - 01/2010
2	Trastuzumab (Herceptin)FDA Link 05/2009 - 10/2008
2	Cisplatin (Platino)FDA LinkGeneric 03/2007 - 10/2002
1	GlucocorticoidsIBA 10/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	Methylprednisolone FDA LinkGeneric 10/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	AnticoagulantsIBA 12/2021
1	Insulin-Like PeptidesIBA 06/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	ChromatinIBA 01/2021

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
26	Therapeutics 10/2022 - 04/2003
10	Adjuvant Chemotherapy 01/2017 - 07/2002
9	Neoadjuvant Therapy 02/2022 - 01/2013
4	Radiotherapy 02/2022 - 02/2003
3	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 01/2016
3	Induction Chemotherapy 01/2020 - 07/2004
2	Immunotherapy 01/2021 - 11/2005
2	Chemoradiotherapy 01/2020 - 07/2004
2	Catheters 05/2016 - 07/2012
2	Aftercare (After-Treatment) 01/2011 - 08/2006
2	Transplantation 05/2009 - 05/2006
2	Stem Cell Transplantation 05/2009 - 11/2005
2	Hematopoietic Stem Cell Transplantation 04/2007 - 03/2005
2	Combination Drug Therapy (Combination Chemotherapy) 03/2007 - 08/2006
1	Segmental Mastectomy (Lumpectomy) 09/2022
1	Mastectomy (Mammectomy) 09/2022
1	Noninvasive Ventilation 12/2021
1	Continuous Positive Airway Pressure 12/2021
1	Investigational Therapies (Experimental Therapy) 01/2021